These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 34927450)

  • 41. Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta-analysis with bias analysis.
    Morrison AE; Zaccardi F; Khunti K; Davies MJ
    Liver Int; 2019 Mar; 39(3):557-567. PubMed ID: 30358050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update on cardiovascular risk in nonalcoholic fatty liver disease.
    Johnston MP; Patel J; Byrne CD
    Curr Opin Cardiol; 2021 Jul; 36(4):478-486. PubMed ID: 34059612
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic Dysfunction-Associated Fatty Liver Disease and Incident Cardiovascular Disease Risk: A Nationwide Cohort Study.
    Lee H; Lee YH; Kim SU; Kim HC
    Clin Gastroenterol Hepatol; 2021 Oct; 19(10):2138-2147.e10. PubMed ID: 33348045
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association of NAFLD with cardiovascular disease and all-cause mortality: a large-scale prospective cohort study based on UK Biobank.
    Ma W; Wu W; Wen W; Xu F; Han D; Lyu J; Huang Y
    Ther Adv Chronic Dis; 2022; 13():20406223221122478. PubMed ID: 36159632
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exploring the Path of Mediterranean Diet, Non-Alcoholic Fatty Liver Disease (NAFLD) and Inflammation towards 10-Year Cardiovascular Disease (CVD) Risk: The ATTICA Study 10-Year Follow-Up (2002-2012).
    George ES; Georgousopoulou EN; Mellor DD; Chrysohoou C; Pitsavos C; Panagiotakos DB
    Nutrients; 2022 Jun; 14(12):. PubMed ID: 35745097
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic predisposition, lifestyle risk, and obesity associate with the progression of nonalcoholic fatty liver disease.
    Liu Z; Suo C; Zhao R; Yuan H; Jin L; Zhang T; Chen X
    Dig Liver Dis; 2021 Nov; 53(11):1435-1442. PubMed ID: 34348882
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using an Electronic Medical Records Database to Identify Non-Traditional Cardiovascular Risk Factors in Nonalcoholic Fatty Liver Disease.
    Corey KE; Kartoun U; Zheng H; Chung RT; Shaw SY
    Am J Gastroenterol; 2016 May; 111(5):671-6. PubMed ID: 26925881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonalcoholic fatty liver disease and cardiovascular disease.
    Liu H; Lu HY
    World J Gastroenterol; 2014 Jul; 20(26):8407-15. PubMed ID: 25024598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease.
    Ng CH; Chan KE; Chin YH; Zeng RW; Tsai PC; Lim WH; Tan DJH; Khoo CM; Goh LH; Ling ZJ; Kulkarni A; Mak LL; Huang DQ; Chan M; Chew NW; Siddiqui MS; Sanyal AJ; Muthiah M
    Clin Mol Hepatol; 2022 Jul; 28(3):565-574. PubMed ID: 35585687
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonalcoholic fatty liver disease and vascular disease: state-of-the-art.
    Fargion S; Porzio M; Fracanzani AL
    World J Gastroenterol; 2014 Oct; 20(37):13306-24. PubMed ID: 25309067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-alcoholic fatty liver disease-related risk of cardiovascular disease and other cardiac complications.
    Byrne CD; Targher G
    Diabetes Obes Metab; 2022 Feb; 24 Suppl 2():28-43. PubMed ID: 34324263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.
    Yoshitaka H; Hamaguchi M; Kojima T; Fukuda T; Ohbora A; Fukui M
    Medicine (Baltimore); 2017 May; 96(18):e6712. PubMed ID: 28471965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between night shift work and NAFLD: a prospective analysis of 281,280 UK Biobank participants.
    Huang H; Liu Z; Xie J; Xu C
    BMC Public Health; 2023 Jul; 23(1):1282. PubMed ID: 37400787
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis.
    Mantovani A; Csermely A; Petracca G; Beatrice G; Corey KE; Simon TG; Byrne CD; Targher G
    Lancet Gastroenterol Hepatol; 2021 Nov; 6(11):903-913. PubMed ID: 34555346
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Associations between an inflammatory diet index and severe non-alcoholic fatty liver disease: a prospective study of 171,544 UK Biobank participants.
    Petermann-Rocha F; Wirth MD; Boonpor J; Parra-Soto S; Zhou Z; Mathers JC; Livingstone K; Forrest E; Pell JP; Ho FK; Hébert JR; Celis-Morales C
    BMC Med; 2023 Apr; 21(1):123. PubMed ID: 37013578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease.
    Arvind A; Henson JB; Osganian SA; Nath C; Steinhagen LM; Memel ZN; Donovan A; Balogun O; Chung RT; Simon TG; Corey KE
    Hepatol Commun; 2022 Feb; 6(2):309-319. PubMed ID: 34558862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Establishment of a machine learning predictive model for non-alcoholic fatty liver disease: A longitudinal cohort study.
    Cao T; Zhu Q; Tong C; Halengbieke A; Ni X; Tang J; Han Y; Li Q; Yang X
    Nutr Metab Cardiovasc Dis; 2024 Jun; 34(6):1456-1466. PubMed ID: 38508988
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-alcoholic fatty liver disease (NAFLD) and the cardiovascular disease (CVD) risk categories in primary care: is there an association?
    Miptah HN; Ramli AS; Mohamad M; Hashim H; Tharek Z
    BMC Fam Pract; 2020 Nov; 21(1):238. PubMed ID: 33218301
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiometabolic risk estimation using exposome data and machine learning.
    Atehortúa A; Gkontra P; Camacho M; Diaz O; Bulgheroni M; Simonetti V; Chadeau-Hyam M; Felix JF; Sebert S; Lekadir K
    Int J Med Inform; 2023 Nov; 179():105209. PubMed ID: 37729839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.